Circulating Tumor Cells Market is anticipated to grow significantly in the coming years owing to the increasing cancer cases. Circulating tumor cells circulate inside the body through blood stream. They comprise seeds that are responsible for the growth of additional tumors in different organs, which cause cancer. Hence, different tumor detection markers are developed for the early discovery of cancer.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/circulating-tumor-cells-ctc-market/request-sample
The key driving factors responsible for the growth of Circulating
Tumor Cells market :
The growth of circulating tumor
cells (CTC) market is influenced by increasing mortality rate due to cancer,
several types of genetic disorders, drastic change in lifestyle, increase in
smoking-causing disorders, and rise in consumption of alcohol. Moreover,
developments in bioengineering technologies, biomedical imaging and rise in
demand for preventive medications for different types of cancers are also
stimulating the market growth of circulating tumor cells. However, the factors
restraining the market growth comprise significant cost of detection
techniques, scarcity of specific biomarkers for the detection of CTCs,
reluctance in the adoption of new technologies, and other technical limits.
Increasing focus of the market
players for the introduction of companion diagnostics for cancer and other
disorders and increase in demand for research projects on cancer are few trends
in the circulating tumor cells industry. Circulating tumor cells market is
categorized on the basis of technology, application, and geography. On the
basis of technology, the market is divided into CTC Detection, CTC Enrichment,
and CTC Analysis. CTC enrichment segment is expected to lead the market owing
to high efficiency due to increased functionalities.
Based on application, circulating
tumor cells (CTC) industry is divided into tumorigenesis research, cancer stem
cell research, EMT biomarkers development, and others.EMT biomarkers
development segment is predicted to hold maximum share of the market due to
advancements in technology.
In terms of end user, circulating
tumor cells (CTC) market is bifurcated into research & academic institutes,
hospitals & clinics, and diagnostic centers. Hospitals and clinics segment
is expected to hold larger share of the market due to increasing preference for
efficient treatment offered at hospitals.
Geographically, CTC industry is
segmented as North America, Latin America, Europe, Asia Pacific, and Middle
East & Africa. North America, followed by Europe accounted for the larger
share of market due to large number of market players and mature healthcare
infrastructure. Asia-Pacific is also expected to grow considerably in the
coming years due to increasing investment and growing technological
advancements in the domain.
View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/circulating-tumor-cells-ctc-market
No comments:
Post a Comment